Simple blood test could replace biopsies for kidney transplant patients
NCT ID NCT07551531
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new blood test called GraftAssure that measures DNA from the donor kidney in the recipient's blood. The goal is to see if this test can detect rejection more accurately than current methods. Researchers will enroll 5,000 kidney transplant patients and follow them over time. If the test works well, it could help doctors catch rejection earlier and avoid some invasive biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GraftAssure blood test (measures donor-derived cell-free DNA)
What this could lead to
If successful, this test could help doctors detect kidney rejection earlier and more accurately, potentially reducing the need for invasive biopsies.
What could go wrong
This is an observational registry study, not a treatment trial. The test may not prove superior to existing methods, and results may not change patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••